Clinical Trial
Controlled Clinical Trial
Journal Article
Add like
Add dislike
Add to saved papers

A comparison of two sources of phytase in liquid and dry forms in broilers.

Poultry Science 2005 Februrary
Research with corn-soybean meal diets was conducted to compare phytase sources in commercial broilers. A Ca to nonphytate P (nPP) ratio of 2.5:1 was maintained in all diets. Experiments 1 and 2 were conducted from d 4 to 13 (experiment 1) or d 9 to 23 post-hatching (experiment 2) in batteries. The 10 treatments used in both experiment were: Diets 1 to 4 = 0.20, 0.25, 0.30, or 0.35% nPP; Diets 5 to 7 = diet 1 plus 100, 200, or 300 phytase units/kg of diet from Natuphos (NAT); and Diets 8 to 10 = diet 1 plus 100, 200, or 300 phytase units/ kg of diet from Ronozyme (RON). As nPP levels increased, daily gain (ADG), feed intake (ADFI), gain:feed, and toe and tibia ash percentage were linearly increased (P < 0.06) in experiments 1 and 2. Incremental addition of phytase, regardless of source, linearly increased (P < 0.07) ADG and ADFI in experiment 1. Broilers fed NAT had higher (P < 0.07) toe ash percentage in experiment 1 and 2, and higher (P < 0.02) ADG and ADFI in experiment 2 than those fed RON. In experiment 3, 3,360 broilers were used to test 2 dry phytase products from 0 to 41 d posthatching in a 3-phase feeding program. The treatments were: Diet 1) adequate Ca and nPP; Diet 2) nPP reduced by 0.20%; Diets 3 to 5 = diet 2 plus 300, 500, or 750 phytase units/kg of diet from NAT; and Diets 6 to 8 = Diet 2 plus 300, 500, or 750 phytase units/kg of diet from RON. Broilers fed the adequate Ca and nPP diet had improved ADG and ADFI overall, and tibia ash weight and percentage in all growth phases (P < 0.03) compared with those fed the reduced Ca and nPP diets. Overall, ADG and ADFI were linearly increased (P < 0.05) by incremental phytase addition in experiment 3. Both NAT and RON produce similar growth and bone ash traits in commercial broilers.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app